U.S. markets open in 1 hour 57 minutes

MDxHealth SA (MDXH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.3300-0.1000 (-4.12%)
At close: 04:00PM EDT
2.3400 +0.01 (+0.43%)
After hours: 04:03PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close2.4300
Bid2.3200 x 200
Ask2.3800 x 100
Day's Range2.3200 - 2.4000
52 Week Range0.3500 - 4.6400
Avg. Volume75,736
Market Cap63.581M
Beta (5Y Monthly)-379,681.88
PE Ratio (TTM)N/A
EPS (TTM)-2.1000
Earnings DateMay 08, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for MDXH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MDxHealth SA
    Daily – Vickers Top Buyers & Sellers for 09/26/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    2 years agoArgus Research
View more
  • TipRanks

    These 2 ‘Strong Buy’ Penny Stocks Could Go Boom, Say Analysts

    Nearly three months into 2024, it’s clear that the bullish trends are here to stay. Markets hit a bottom in late October, but since then the S&P 500 has gained 27% and now stands at more than 5,200. The NASDAQ index is up 30% from its own October 27 low point. These are bull-market numbers, and show little sign of stopping. Watching the market from Oppenheimer, chief investment strategist John Stoltzfus comments on the market outlook: “S&P 500 earnings results over the most recent two quarterly

  • GlobeNewswire

    Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering

    Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering IRVINE, CA, and HERSTAL, BELGIUM – March 12, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”), a commercial-stage precision diagnostic company, announces the introduction of a non-invasive genetic prostate cancer test through its urology sales channel. With a simple saliva sample, the new comprehensive hereditary prostate cancer test offering provides insights into a patient’s risk

  • Insider Monkey

    MDxHealth SA (NASDAQ:MDXH) Q4 2023 Earnings Call Transcript

    MDxHealth SA (NASDAQ:MDXH) Q4 2023 Earnings Call Transcript March 6, 2024 MDxHealth SA misses on earnings expectations. Reported EPS is $-0.39 EPS, expectations were $-0.28. MDXH isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen and […]